NAVALIGN, LLC – Allogene Therapeutics, Inc. Transaction History
NAVALIGN, LLC portfolio value:
$814,000
portfolio value
NAVALIGN, LLC quarter portfolio value change:
-5.26%
quarter
Allogene Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -45K | $10.8 | 75.36K | |
| Q2 2022 | share | Increase | +1.47% | 1.09K shares | 236K | $11.4 | 75.36K |
| Q1 2022 | share | Increase | +15.28% | 9.84K shares | -338K | $9.11 | 74.27K |
| Q4 2021 | share | 0.00% | 0 shares | -695K | $15.38 | 64.42K | |
| Q3 2021 | share | 0.00% | 0 shares | -24K | $25.7 | 64.42K | |
| Q2 2021 | share | Increase | 0.00% | 64.42K shares | 1.68M | $26.08 | 64.42K |